Researchers at Michigan Medicine have identified a new way to measure the impact of treatment on bipolar disorder, focusing instead on how much patients vary from their typical mood or how big their “spikes” are and work to reduce the size of those spikes through established or experimental treatments. Sarah Sperry, Ph.D., helped develop the new scoring system and underscored its impact and how it can help patients.
